User profiles for Kartikeya Cherabuddi

Kartikeya Cherabuddi, MD, FACP, FIDSA

University of Florida
Verified email at ufl.edu
Cited by 1983

[HTML][HTML] Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients

…, K Subramaniam, TB Waltzek, K Cherabuddi… - International Journal of …, 2020 - Elsevier
Objectives Because the detection of SARS-CoV-2 RNA in aerosols but failure to isolate viable
(infectious) virus are commonly reported, there is substantial controversy whether severe …

India's COVID-19 crisis: a call for international action

K Kuppalli, P Gala, K Cherabuddi, SP Kalantri… - The Lancet, 2021 - thelancet.com
MC has received grants paid to her institution from the US National Institute of Mental Health
(NIMH) and the South African Medical Research Council (# R01MH106600), the Fogarty …

Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar

AH Kelkar, JA Blake, K Cherabuddi, H Cornett… - Healthcare, 2021 - mdpi.com
(1) Background: Vaccine hesitancy and rejection are major threats to controlling coronavirus
disease 2019 (COVID-19). There is a paucity of information about the attitudes of cancer …

Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase–producing Enterobacteriaceae: a …

…, MY Lin, M McNally, K Cherabuddi… - Infection Control & …, 2012 - cambridge.org
Objective.To determine whether transfer from a long-term care facility (LTCF) is a risk factor
for colonization with Klebsiella pneumoniae carbapenemase (KPC)–producing …

Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a WikiGuidelines group consensus statement

…, M Angarone, RM Centor, K Cherabuddi… - JAMA network …, 2022 - jamanetwork.com
Importance Traditional approaches to practice guidelines frequently result in dissociation
between strength of recommendation and quality of evidence. Objective To construct a clinical …

Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients

MH Al-Shaer, E Rubido, K Cherabuddi… - Journal of …, 2020 - academic.oup.com
Background In the ICU, early and appropriate antimicrobial therapy is important to lower
infection-related mortality. Objectives Assess whether achieving early β-lactam free …

[HTML][HTML] Chloroquine and hydroxychloroquine in the context of COVID-19

…, AW Shukla, HJ Mehta, K Cherabuddi - Drugs in …, 2020 - ncbi.nlm.nih.gov
… ; Kartikeya Cherabuddi was involved in the organization, review, and critique of the
manuscript. All named authors meet the International Committee of Medical Journal Editors (ICMJE) …

Coinfection with Zika and dengue-2 viruses in a traveler returning from Haiti, 2016: clinical presentation and genetic analysis

NM Iovine, J Lednicky, K Cherabuddi… - Clinical Infectious …, 2016 - academic.oup.com
Zika virus and dengue virus serotype 2 were isolated from a patient with travel to Haiti who
developed fever, rash, arthralgias, and conjunctivitis. The infecting Zika virus was related to …

Population pharmacokinetics and target attainment of cefepime in critically ill patients and guidance for initial dosing

…, MN Neely, J Liu, K Cherabuddi… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Cefepime is commonly used in the intensive care unit (ICU) to treat bacterial infections. The
time during which the free cefepime concentration is above the MIC (fT >MIC ) should be …

Performance of a semiquantitative multiplex bacterial and viral PCR panel compared with standard microbiological laboratory results: 396 patients studied with the …

KH Rand, SG Beal, K Cherabuddi… - Open Forum …, 2021 - academic.oup.com
Background Microbiologic results are critical to optimal management of patients with lower
respiratory tract infection, but standard methods may take several days. The multiplex …